Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

10819	Companies
234577	Keywords
163431	Articles
125527	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 11/18/2025 at 13:05, 8 months 23 days ago

Moderna présentera ses services lors de la conférence sur les soins de santé de Piper Sandler.

Presentation Aux Investisseurs Moderna Conférence Sur Les Soins De Santé Technologie De L'ARNm Piper Sandler
PRESS RELEASE

published on 11/18/2025 at 13:00, 8 months 23 days ago

Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025
Moderna, Inc. announces participation in Piper Sandler's 37th Annual Healthcare Conference on December 2nd. Webcast available. Moderna revolutionizes mRNA medicine for disease treatment and prevention

Investor Relations MRNA Medicine Moderna Healthcare Conference Piper Sandler
BRIEF

published on 11/06/2025 at 13:05, 9 months 5 days ago

Moderna annonce un chiffre d'affaires d'un milliard de dollars au troisième trimestre 2025, malgré des prévisions financières revues à la baisse pour 2025.

Résultats Financiers Moderna Baisse Des Revenus Vaccin Contre Le Covid-19 Efficacité En Matière De Coûts
BRIEF

published on 11/06/2025 at 13:05, 9 months 5 days ago

Moderna Reports $1 Billion Revenue in Q3 2025 Amidst Narrowed 2025 Financial Projections

Financial Results COVID-19 Vaccine Revenue Decline Moderna Cost Efficiency
PRESS RELEASE

published on 11/06/2025 at 13:00, 9 months 5 days ago

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates
Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed

Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF

published on 11/03/2025 at 13:05, 9 months 8 days ago

Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy

Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF

published on 11/03/2025 at 13:05, 9 months 8 days ago

Moderna lance un essai de phase 1/2 pour un traitement du myélome multiple

Moderna Myélome Multiple Étude De Phase 1/2 ARNm-2808 Engager Les Lymphocytes T
PRESS RELEASE

published on 11/03/2025 at 13:00, 9 months 8 days ago

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma
Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms

Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF

published on 10/23/2025 at 20:47, 9 months 18 days ago

Moderna reconnue comme l'un des meilleurs employeurs pour la onzième année consécutive

Innovation Moderne ARNm Meilleur Employeur MNEXSPIKE
BRIEF

published on 10/23/2025 at 20:47, 9 months 18 days ago

Moderna Recognized as Top Employer for Eleventh Year in a Row

Innovation Moderna MRNA Top Employer MNEXSPIKE

Accesswire

Published on 08/11/2026 at 14:30, 1 hour 26 minutes ago

ACCESS Newswire Reports Second Quarter 2026 Results
Published on 08/11/2026 at 14:30, 1 hour 26 minutes ago

AIAI Holdings' Constellation Network Launches Dôr Retail Intelligence: Transformational AI-Powered Retail Intelligence
Published on 08/11/2026 at 14:00, 1 hour 56 minutes ago

First Canadian Graphite Signs Agreement with Groupe Nipi, in Collaboration with BBA, for its Preliminary Environmental Study at Lac Guéret Sud
Published on 08/11/2026 at 14:00, 1 hour 56 minutes ago

First Canadian Graphite conclut une entente avec le Groupe Nipi en collaboration avec la firme BBA pour une étude environnementale préliminaire au Lac Guéret Sud
Published on 08/11/2026 at 13:30, 2 hours 26 minutes ago

Nextech3D.ai CEO Evan Gappelberg Purchases 250,000 Shares in Open Market

View all ACCESSWIRE

EQS Group

Published on 08/11/2026 at 15:46, 10 minutes ago

GANÉ Value Event Fund: Target cash distribution of 4 per cent per year achieved
Published on 08/11/2026 at 15:25, 30 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/11/2026 at 15:25, 31 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 08/11/2026 at 15:24, 32 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 08/11/2026 at 15:23, 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 08/10/2026 at 18:00, 21 hours 56 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 21 hours 56 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 22 hours 11 minutes ago

Weekly share buyback
Published on 08/10/2026 at 17:45, 22 hours 11 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 1 day 4 hours ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

View all LES ECHOS COMFI WIRE